Cell-free DNA Analysis for Noninvasive Examination of Trisomy
Open accessThe DOI matches its Crossref record; 32 of the 32 references it cites were found in a registry or an index.
Abstract
BACKGROUND: Cell-free DNA (cfDNA) testing for fetal trisomy is highly effective among high-risk women. However, there have been few direct, well-powered studies comparing cfDNA testing with standard screening during the first trimester in routine prenatal populations. METHODS: In this prospective, multicenter, blinded study conducted at 35 international centers, we assigned pregnant women presenting for aneuploidy screening at 10 to 14 weeks of gestation to undergo both standard screening (with measurement of nuchal translucency and biochemical analytes) and cfDNA testing. Participants received the results of standard screening; the results of cfDNA testing were blinded. Determination of the birth outcome was based on diagnostic genetic testing or newborn examination. The primary outcome was the area under the receiver-operating-characteristic curve (AUC) for trisomy 21 (Down's syndrome) with cfDNA testing versus standard screening. We also evaluated cfDNA testing and standard screening to assess the risk of trisomies 18 and 13. RESULTS: Of 18,955 women who were enrolled, results from 15,841 were available for analysis. The mean maternal age was 30.7 years, and the mean gestational age at testing was 12.5 weeks. The AUC for trisomy 21 was 0.999 for cfDNA testing and 0.958 for standard screening (P=0.001). Trisomy 21 was detected in 38 of 38 women (100%; 95% confidence interval [CI], 90.7 to 100) in the cfDNA-testing group, as compared with 30 of 38 women (78.9%; 95% CI, 62.7 to 90.4) in the standard-screening group (P=0.008). False positive rates were 0.06% (95% CI, 0.03 to 0.11) in the cfDNA group and 5.4% (95% CI, 5.1 to 5.8) in the standard-screening group (P<0.001). The positive predictive value for cfDNA testing was 80.9% (95% CI, 66.7 to 90.9), as compared with 3.4% (95% CI, 2.3 to 4.8) for standard screening (P<0.001). CONCLUSIONS: In this large, routine prenatal-screening population, cfDNA testing for trisomy 21 had higher sensitivity, a lower false positive rate, and higher positive predictive value than did standard screening with the measurement of nuchal translucency and biochemical analytes. (Funded by Ariosa Diagnostics and Perinatal Quality Foundation; NEXT ClinicalTrials.gov number, NCT01511458.).
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Similarly, cfDNA analysis has been useful for non-invasive prenatal testing applications, such as for the identification of trisomy 21 (ref.124).”
From Clinical metagenomics (2019) · cites this paper as [124]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
DeLong, E. R., DeLong, D. M., & Clarke-Pearson, D. L. (1988) · Biometrics · doi:10.2307/2531595 · Cited by 22,649
First-Trimester or Second-Trimester Screening, or Both, for Down's Syndrome
Malone, F. D., Canick, J. A., Ball, R. H., Nyberg, D. A., Comstock, C. H., Bukowski, R., Berkowitz, R. L., Gross, S. J., Dugoff, L., Craigo, S. D., et al. (2005) · New England Journal of Medicine · doi:10.1056/nejmoa043693 · Cited by 1,081
Palomaki, G. E., Kloza, E. M., Lambert-Messerlian, G. M., Haddow, J. E., Neveux, L. M., Ehrich, M., van den Boom, D., Bombard, A. T., Deciu, C., Grody, W. W., et al. (2011) · Genetics in Medicine · doi:10.1097/gim.0b013e3182368a0e · Cited by 939
Gil, M. M., Quezada, M. S., Revello, R., Akolekar, R., & Nicolaides, K. H. (2015) · Ultrasound in Obstetrics & Gynecology · doi:10.1002/uog.14791 · Cited by 807
Akolekar, R., Beta, J., Picciarelli, G., Ogilvie, C., & D'Antonio, F. (2015) · Ultrasound in Obstetrics & Gynecology · doi:10.1002/uog.14636 · Cited by 711
Noninvasive prenatal testing for fetal trisomies in a routinely screened first-trimester population
Nicolaides, K. H., Syngelaki, A., Ashoor, G., Birdir, C., & Touzet, G. (2012) · American Journal of Obstetrics and Gynecology · doi:10.1016/j.ajog.2012.08.033 · Cited by 624
DNA Sequencing versus Standard Prenatal Aneuploidy Screening
Bianchi, D. W., Parker, R. L., Wentworth, J., Madankumar, R., Saffer, C., Das, A. F., Craig, J. A., Chudova, D. I., Devers, P. L., Jones, K. W., et al. (2014) · New England Journal of Medicine · doi:10.1056/nejmoa1311037 · Cited by 620
Norton, M. E., Brar, H., Weiss, J., Karimi, A., Laurent, L. C., Caughey, A. B., Rodriguez, M. H., Williams, J., Mitchell, M. E., Adair, C. D., et al. (2012) · American Journal of Obstetrics and Gynecology · doi:10.1016/j.ajog.2012.05.021 · Cited by 596
Self-citationFirst-Trimester Screening for Trisomies 21 and 18
Wapner, R., Thom, E., Simpson, J. L., Pergament, E., Silver, R., Filkins, K., Platt, L., Mahoney, M., Johnson, A., Hogge, W. A., et al. (2003) · New England Journal of Medicine · doi:10.1056/nejmoa025273 · Cited by 563
Self-citationDNA Sequencing Versus Standard Prenatal Aneuploidy Screening
Rochon, M. L. (2014) · Cited by 468
Cited by
Items 301–400 of 817
Implementation of non‐invasive prenatal testing by semiconductor sequencing in a genetic laboratory
Dheedene, A., Sante, T., Smet, M. D., Vanbellinghen, J.-F., Grisart, B., Vergult, S., Janssens, S., & Menten, B. (2016) · Prenatal Diagnosis · doi:10.1002/pd.4841 · Cited by 15
Clinical utility of emerging liquid biomarkers in advanced prostate cancer
Vandekerkhove, G. R., Chi, K. N., & Wyatt, A. W. (2017) · Cancer Genetics · doi:10.1016/j.cancergen.2017.08.003 · Cited by 17
The Effect of Maternal Obesity on Placental Cell-Free DNA Release in a Mouse Model
Mhatre, M., Adeli, S., Norwitz, E. R., Craigo, S., Phillippe, M., & Edlow, A. G. (2018) · Reproductive Sciences · doi:10.1177/1933719118811647 · Cited by 14
Prefumo, F., Paolini, D., Speranza, G., Palmisano, M., Dionisi, M., & Camurri, L. (2019) · PLoS ONE · doi:10.1371/journal.pone.0218166 · Cited by 15
Bardi, F., Bet, B., Pajkrt, E., Linskens, I. H., Bekker, M. N., Sistermans, E. A., Bilardo, C. M., & Elvan‐Taşpınar, A. (2022) · Prenatal Diagnosis · doi:10.1002/pd.6238 · Cited by 15
Kelley, J., Henning, G. F., Ambrose, A., & Adelman, A. (2016) · The Journal of the American Board of Family Medicine · doi:10.3122/jabfm.2016.03.150196 · Cited by 15
Informed decision-making about prenatal cfDNA screening: An assessment of written materials
Michie, M., Kraft, S. A., Minear, M. A., Ryan, R. R., & Allyse, M. A. (2016) · Ethics Medicine and Public Health · doi:10.1016/j.jemep.2016.05.004 · Cited by 15
Prenatal Diagnosis of Chromosomal Abnormalities through Chorionic Villus Sampling and Amniocentesis
BENN, P. A. (2015) · Wiley eBooks · doi:10.1002/9781118981559.ch4 · Cited by 20
Population monitoring of trisomy 21: problems and approaches
Sperling, K., Scherb, H., & Neitzel, H. (2023) · Molecular Cytogenetics · doi:10.1186/s13039-023-00637-1 · Cited by 23
DNA methylation in necrotizing enterocolitis
Frazer, L. C., Yamaguchi, Y., Singh, D. K., Akopyants, N. S., & Good, M. L. (2024) · Expert Reviews in Molecular Medicine · doi:10.1017/erm.2024.16 · Cited by 16
Wei, Y., Zhen, J., Hu, L., Gu, Y., Liu, Y., Guo, X., Yang, Z., Zheng, H., Cheng, S., Wei, F., et al. (2024) · Nature Communications · doi:10.1038/s41467-024-52236-2 · Cited by 19
How Effective Is First-Trimester Screening for Trisomy 21 Based on Ultrasound Only?
Wiechec, M. T., Knafel, A., Nocuń, A., Matyszkiewicz, A., Juszczak, M., Wiercińska, E., & Latała, E. (2015) · Fetal Diagnosis and Therapy · doi:10.1159/000434632 · Cited by 16
Unfair discrimination in prenatal aneuploidy screening using cell-free DNA?
Rolfes, V., & Schmitz, D. (2015) · European Journal of Obstetrics & Gynecology and Reproductive Biology · doi:10.1016/j.ejogrb.2015.12.023 · Cited by 16
Maxwell, S. J., O'Leary, P. C., Dickinson, J. E., & Suthers, G. (2017) · Australian and New Zealand Journal of Obstetrics and Gynaecology · doi:10.1111/ajo.12612 · Cited by 14
Ngan, O. M. Y., Yi, H., Wong, S. Y. S., Sahota, D. S., & Ahmed, S. (2017) · BMC Pregnancy and Childbirth · doi:10.1186/s12884-017-1474-6 · Cited by 18
Langlois, S., Johnson, J.-A. M., Audibert, F., Gekas, J., Forest, J., Caron, A., Harrington, K., Pastuck, M., Meddour, H., Têtu, A., et al. (2017) · Prenatal Diagnosis · doi:10.1002/pd.5174 · Cited by 17
Zhang, Q., Zhang, K., Guo, Y., Wei, X., Sun, Y., Cai, B., Shi, Y., Du, Y., Liu, Y., Fan, C., et al. (2021) · Journal of Materials Chemistry B · doi:10.1039/d1tb00005e · Cited by 14
Huang, T., Meschino, W. S., Teitelbaum, M., Dougan, S., & Okun, N. B. (2017) · Journal of Obstetrics and Gynaecology Canada · doi:10.1016/j.jogc.2017.01.025 · Cited by 14
Single Nucleotide Polymorphism-Based Noninvasive Prenatal Testing: Experience in India
Verma, I. C., Puri, R. D., Venkataswamy, E., Tayal, T., Nampoorthiri, S., Andrew, C., Kabra, M., Bagga, R., Gowda, M., Batra, M., et al. (2018) · The Journal of Obstetrics and Gynecology of India · doi:10.1007/s13224-017-1061-9 · Cited by 15
Noh, J. J., Ryu, H. M., Oh, S., Choi, S., Roh, C., & Kim, J.-H. (2019) · Taiwanese Journal of Obstetrics and Gynecology · doi:10.1016/j.tjog.2019.05.021 · Cited by 15
Choe, S., Seol, H., Kwon, J. Y., Park, C., Kim, M. H., Lee, J. Y., Kim, M., Hwang, H. S., Na, S., Shim, J., et al. (2021) · Journal of Korean Medical Science · doi:10.3346/jkms.2021.36.e27 · Cited by 14
Klimczak, A. M., Reig, A., Neal, S. A., Seli, E. U., & Scott, R. T. (2020) · American Journal of Obstetrics & Gynecology MFM · doi:10.1016/j.ajogmf.2020.100232 · Cited by 15
Use of Cell-free DNA to Screen for Down's Syndrome
Chitty, L. S. (2015) · New England Journal of Medicine · doi:10.1056/nejme1502441 · Cited by 14
van Eekhout, J. C. A., Bax, C. J., Schuurman, L. V. P., Becking, E. C., van der Ven, A. J. E. M., Opstal, D. V., Boon, E. M. J., Macville, M. V. E., Bekker, M. N., & Galjaard, R. H. (2025) · Ultrasound in Obstetrics and Gynecology · doi:10.1002/uog.70015 · Cited by 17
Rate of no result in cell‐free DNA testing and its influence on test performance metrics
Grati, F. R., & Kagan, K. O. (2016) · Ultrasound in Obstetrics and Gynecology · doi:10.1002/uog.17330 · Cited by 13
Non-invasive prenatal testing (NIPT): is routinization problematic?
Rehmann‐Sutter, C., Timmermans, D. R. M., & Raz, A. E. (2023) · BMC Medical Ethics · doi:10.1186/s12910-023-00970-5 · Cited by 13
Dadam, M. N., Hien, L. T., Makram, E. M., Lam, V. S., Morad, A., Khalil, N., Tran, L. T., Makram, A. M., & Huy, N. T. (2024) · PLoS ONE · doi:10.1371/journal.pone.0305895 · Cited by 15
Maxwell, S. J., Dickinson, J. E., Murch, A. R., & O'Leary, P. C. (2015) · Australian and New Zealand Journal of Obstetrics and Gynaecology · doi:10.1111/ajo.12385 · Cited by 13
Suskin, E., Hercher, L., Aaron, K. E., & Bajaj, K. (2016) · Journal of Genetic Counseling · doi:10.1007/s10897-016-9934-0 · Cited by 17
Novel Approaches to an Integrated Route for Trisomy 21 Evaluation
Buczyńska, A., Sidorkiewicz, I., Trochimiuk, A., Ławicki, S., Kretowski, A. J., & Zbucka-Krętowska, M. (2021) · Biomolecules · doi:10.3390/biom11091328 · Cited by 13
Biomarker Development Using Liquid Biopsy in Hepatocellular Carcinoma
Grinspan, L. T., & Villanueva, A. (2022) · Seminars in Liver Disease · doi:10.1055/s-0042-1748924 · Cited by 14
Kantor, V., Mo, L., DiNonno, W., Howard, K. L., Palsuledesai, C. C., Parmar, S., Chithiwala, Z. H., Jelsema, R., Xu, W., & Hedriana, H. L. (2022) · Prenatal Diagnosis · doi:10.1002/pd.6262 · Cited by 13
Liu, Y., Sun, X., Lv, G., Liu, J., Sun, C., & Mu, K. (2023) · Journal of Comparative Effectiveness Research · doi:10.57264/cer-2022-0168 · Cited by 17
Unmet needs: Research helps regulators do their jobs
Altman, R. B., Khuri, N., Salit, M., & Giacomini, K. M. (2015) · Science Translational Medicine · doi:10.1126/scitranslmed.aac4369 · Cited by 14
Zheng, Y., Wan, S., Dang, Y., Song, T., Chen, B., & Zhang, J. (2019) · Ginekologia Polska · doi:10.5603/gp.2019.0050 · Cited by 13
Gou, L., Fang, Y., Wang, N., Zhang, M., Liu, T., Wang, Y., Hu, S., Zhang, Y., Wu, Q., Wang, Y., et al. (2020) · Journal of International Medical Research · doi:10.1177/0300060520966877 · Cited by 13
Women should decide which conditions matter
Norton, M. E., & Kuppermann, M. (2016) · American Journal of Obstetrics and Gynecology · doi:10.1016/j.ajog.2016.06.045 · Cited by 13
Self-citationScarff, K. L., Flowers, N. J., Love, C. J., Archibald, A. D., Hunt, C. E., Giouzeppos, O., Elliott, J., Delatycki, M. B., & Pertile, M. D. (2023) · Prenatal Diagnosis · doi:10.1002/pd.6307 · Cited by 12
Connor, C., Sato, T., Bianchi, D. W., Fenton, K. N., Somani, E., Turriff, A. E., Berkman, B. E., & Hendriks, S. (2025) · Prenatal Diagnosis · doi:10.1002/pd.6708 · Cited by 14
Cell-free DNA versus intact fetal cells for prenatal genetic diagnostics: what does the future hold?
Wou, K., Feinberg, J. L., Wapner, R. J., & Simpson, J. L. (2015) · Expert Review of Molecular Diagnostics · doi:10.1586/14737159.2015.1051529 · Cited by 15
Self-citationBENN, P. A. (2016) · American Journal of Obstetrics and Gynecology · doi:10.1016/j.ajog.2016.01.003 · Cited by 12
White, K. L., Wang, Y., Kunz, L., & Schmid, M. (2019) · The Journal of Maternal-Fetal & Neonatal Medicine · doi:10.1080/14767058.2019.1594190 · Cited by 15
Evaluation of the clinical performance of noninvasive prenatal testing at a Japanese laboratory
Sasaki, Y., Yamada, T., Tanaka, S., Sekizawa, A., Hirose, T., Suzumori, N., Kaji, T., Kawaguchi, S., Hasuo, Y., Nishizawa, H., et al. (2021) · Journal of obstetrics and gynaecology research · doi:10.1111/jog.14954 · Cited by 12
Wang, S., Liu, K., Yang, H., & Ma, J. (2019) · Frontiers in Public Health · doi:10.3389/fpubh.2022.870543 · Cited by 14
Franchi, P. G., Palka, C., Morizio, E., Sabbatinelli, G., Alfonsi, M., Fantasia, D., Sitar, G., BENN, P. A., & Calabrese, G. (2017) · PLoS ONE · doi:10.1371/journal.pone.0189235 · Cited by 12
Sun, X., Lu, J., & Ma, X. (2019) · PLoS ONE · doi:10.1371/journal.pone.0215368 · Cited by 12
Muzzey, D., Goldberg, J. D., & Haverty, C. E. (2019) · Prenatal Diagnosis · doi:10.1002/pd.5603 · Cited by 16
Geppert, J., Stinton, C., Johnson, S. A., Clarke, A., Grammatopoulos, D. K., & Taylor‐Phillips, S. (2019) · Prenatal Diagnosis · doi:10.1002/pd.5621 · Cited by 15
Silvestri, M., Reduzzi, C., Feliciello, G., Vismara, M., Schamberger, T., Köstler, C., Motta, R., Calza, S., Ferraris, C., Vingiani, A., et al. (2021) · Cancers · doi:10.3390/cancers13061409 · Cited by 12
Vong, J. S. L., Jiang, P., Cheng, S., Lee, W., Tsang, J. C. H., Leung, T.-Y., Chan, K. C. A., Chiu, R. W. K., & Lo, Y. M. D. (2018) · Prenatal Diagnosis · doi:10.1002/pd.5406 · Cited by 12
Bai, T., Liu, S., Liu, J., Jing, X., Deng, C., Xia, T., Liu, Y., Cheng, J. L., Li, Z., Wei, X., et al. (2021) · The Journal of Maternal-Fetal & Neonatal Medicine · doi:10.1080/14767058.2021.1903860 · Cited by 11
Madala, D., Maktabi, M. A., Sabbagh, R., Erfani, H., Moon, A., & den Veyver, I. B. V. (2022) · Prenatal Diagnosis · doi:10.1002/pd.6221 · Cited by 13
Okoror, C. E. M., & Arora, S. (2023) · European Journal of Obstetrics & Gynecology and Reproductive Biology X · doi:10.1016/j.eurox.2023.100211 · Cited by 20
Langmajerová, M. S., Pelcová, M., Vedrová, P., Celá, A., & Glatz, Z. (2021) · Electrophoresis · doi:10.1002/elps.202100328 · Cited by 11
Yuan, X., Han, X., Jia, C., Zhou, W., & Yu, B. (2022) · International Journal of Women s Health · doi:10.2147/ijwh.s364554 · Cited by 11
Non‐invasive prenatal testing for everybody or contingent screening?
van der Meij, K. R. M., Henneman, L., & Sistermans, E. A. (2022) · Prenatal Diagnosis · doi:10.1002/pd.6296 · Cited by 16
Saidel, M. L., Ananth, U. S., Rose, D. T., & Farrell, C. (2023) · Journal of Clinical Laboratory Analysis · doi:10.1002/jcla.24870 · Cited by 11
What is prenatal screening and why to do it?
Temming, L. A., & Macones, G. A. (2015) · Seminars in Perinatology · doi:10.1053/j.semperi.2015.11.002 · Cited by 14
Sun, L., Fan, Z., Long, J., Weng, X., Tang, W., & Pang, W. (2017) · Gene · doi:10.1016/j.gene.2017.06.014 · Cited by 11
Gerson, K. D., & O’Brien, B. M. (2018) · Obstetrics and Gynecology Clinics of North America · doi:10.1016/j.ogc.2017.11.001 · Cited by 11
Kaseniit, K. E., Hogan, G. J., D’Auria, K. M., Haverty, C. E., & Muzzey, D. (2018) · BMC Medical Genomics · doi:10.1186/s12920-018-0410-6 · Cited by 10
Tobin, M. R., Gunaji, R., Walsh, J. C., & Grice, G. P. (2019) · American Journal of Medical Genetics Part A · doi:10.1002/ajmg.a.61255 · Cited by 13
Silva, A. J. D. M., Lucena, J. P., & Hueneburg, T. (2019) · Cell Biology International · doi:10.1002/cbin.11286 · Cited by 11
Yao, H., Gao, Y. M., Zhao, J., Zhang, R., Xu, H., Hu, H., Luo, Y., Yuan, Y., Fu, M., Zhang, H., et al. (2018) · Science China Life Sciences · doi:10.1007/s11427-017-9344-7 · Cited by 11
Cell‐free DNA screening in twin pregnancies: A more accurate and reliable screening tool
Chibuk, J., Rafalko, J. M., Boomer, T., McCullough, R. M., McLennan, G., WYATT, P. R., & Almasri, E. (2020) · Prenatal Diagnosis · doi:10.1002/pd.5797 · Cited by 11
Harper, J. C., Aittomäki, K., Borry, P., Cornel, M. C., de Wert, G. M. W. R., Dondorp, W., Geraedts, J. P. M., Gianaroli, L., Ketterson, K., Liebaers, I., et al. (2017) · Human Reproduction Open · doi:10.1093/hropen/hox015 · Cited by 13
Committee Opinion No. 640: Cell-Free Dna Screening For Fetal Aneuploidy
(2015) · Obstetrics & Gynecology · doi:10.1097/aog.0000000000001051 · Cited by 349
Shekhawat, D. S., Sharma, C., Singh, K., Singh, P., Bhardwaj, A., & Patwa, P. (2022) · Congenital Anomalies · doi:10.1111/cga.12481 · Cited by 12
NIPTRIC: an online tool for clinical interpretation of non-invasive prenatal testing (NIPT) results
Sikkema‐Raddatz, B., Johansson, L. F., de Boer, E. N., Boon, E. M. J., Suijkerbuijk, R. F., Bouman, K., Bilardo, C. M., Swertz, M. A., Dijkstra, M., van Langen, I. M., et al. (2016) · Scientific Reports · doi:10.1038/srep38359 · Cited by 11
Development of a comprehensive noninvasive prenatal test
Malcher, C., Yamamoto, G. L., Burnham, P., Ezquina, S., Lourenço, N. C. V., Balkassmi, S., Antônio, D. S. M., Hsia, G. S. P., Gollop, T. R., Pavanello, R. C. M., et al. (2018) · Genetics and Molecular Biology · doi:10.1590/1678-4685-gmb-2017-0177 · Cited by 10
Pertile, M. D. (2018) · Elsevier eBooks · doi:10.1016/b978-0-12-814189-2.00007-4 · Cited by 13
Cell‐free DNA testing: how to choose which laboratory to use?
Jani, J. C., de Sousa, M. J. R., & Benachi, A. (2015) · Ultrasound in Obstetrics and Gynecology · doi:10.1002/uog.15733 · Cited by 11
Liu, Y., Jing, X., Xing, L., Liu, S., Liu, J., Cheng, J., Deng, C., Bai, T., Xia, T., Wei, X., et al. (2021) · Frontiers in Genetics · doi:10.3389/fgene.2021.793894 · Cited by 12
Hou, Y., Yang, J., Deng, F., Wang, F., Peng, H., Guo, F., Wang, D., & Yin, A. (2023) · Scientific Reports · doi:10.1038/s41598-023-38151-4 · Cited by 12
Fetal sex determination in twin pregnancies using cell free fetal DNA analysis
Milán, M., Mateu, E., Blesa, D., Císcar, M. C., & Simón, C. (2018) · Prenatal Diagnosis · doi:10.1002/pd.5274 · Cited by 10
Karlsson, F., Ahola, T., Dahlberg, J., Prensky, L., Moilanen, H., & Spalding, H. (2021) · Acta Obstetricia Et Gynecologica Scandinavica · doi:10.1111/aogs.14125 · Cited by 11
More attention should be paid to pregnant women who fail non-invasive prenatal screening
Zhang, B., Zhou, L., Feng, C., Liu, J., & Yu, B. (2021) · Clinical Biochemistry · doi:10.1016/j.clinbiochem.2021.07.004 · Cited by 10
Yang, J., Chen, M., Shen, W., Wu, H., Shou, J., Sun, J., & Wu, W. (2021) · Prenatal Diagnosis · doi:10.1002/pd.6075 · Cited by 13
Cost‐effectiveness of ultrasound before non‐invasive prenatal screening for fetal aneuploidy
Battarbee, A. N., Vora, N. L., Hardisty, E., & Stamilio, D. M. (2022) · Ultrasound in Obstetrics and Gynecology · doi:10.1002/uog.26100 · Cited by 13
Su, B., Jones, R., Chen, K. S., Kostenko, E., Schmid, M., DeMaria, A. L., Villa, A., Swarup, M., Weida, J., & Tuuli, M. G. (2024) · Patient Education and Counseling · doi:10.1016/j.pec.2024.108557 · Cited by 14
IONA test for first‐trimester detection of trisomies 21, 18 and 13
Poon, L. C., Dumidrascu‐Diris, D., Francisco, C., Fantasia, I., & Nicolaides, K. H. (2015) · Ultrasound in Obstetrics and Gynecology · doi:10.1002/uog.15749 · Cited by 10
Farrell, R. M., Agatisa, P. K., Mercer, M. B., Mitchum, A., & Coleridge, M. B. (2016) · Ethics Medicine and Public Health · doi:10.1016/j.jemep.2016.05.002 · Cited by 11
Zhang, B., Zhao, S., Wan, H., Liu, Y., Zhang, F., Guo, X., Zeng, W., Zhang, H., Zeng, L., Qu, J., et al. (2020) · The Analyst · doi:10.1039/d0an00813c · Cited by 10
Not all low fetal fraction cell‐free DNA screening failures are at increased risk for aneuploidy
Caldwell, S., Almasri, E., Schmidt, L. C., Xu, C., Dyr, B., Wardrop, J., & Cacheris, P. (2021) · Prenatal Diagnosis · doi:10.1002/pd.5918 · Cited by 10
Goh, S. K., Cox, D. R. A., Wong, B. K. L., Musafer, A., Witkowski, T., Do, H., Muralidharan, V., & Dobrovic, A. (2021) · Clinical Chemistry · doi:10.1093/clinchem/hvab095 · Cited by 10
Update on Immune Monitoring in Heart Transplantation
Crespo-Leiro, M. G., Barge‐Caballero, E., Paniagua-Martín, M. J., Barge‐Caballero, G., & Suárez-Fuentetaja, N. (2015) · Current Transplantation Reports · doi:10.1007/s40472-015-0081-6 · Cited by 10
Wang, J., Wang, Z., Zhou, Q., Zhang, B., Yin, T., Yu, B., & Wang, L. (2019) · Annals of Translational Medicine · doi:10.21037/atm.2019.06.70 · Cited by 12
Inferring fetal fractions from read heterozygosity empowers the noninvasive prenatal screening
Dang, M., Xu, H., Zhang, J., Wang, W., Bai, L., Fang, N., Liang, L., Zhang, J., Liu, F., Wu, Q., et al. (2019) · Genetics in Medicine · doi:10.1038/s41436-019-0636-5 · Cited by 10
Haidong, W., Zhijie, Y., Picchiassi, E., Tarquini, F., Coata, G., Wang, Y., Youxiang, W., Chen, Y., & Renzo, G. C. D. (2020) · medRxiv · doi:10.1101/2020.12.19.20248553 · Cited by 10
Korlimarla, A., Hart, S. J., Spiridigliozzi, G. A., & Kishnani, P. S. (2020) · Wiley eBooks · doi:10.1002/9781119432692.ch24 · Cited by 13
Dewantiningrum, J., Andonotopo, W., Bachnas, M. A., Pramono, M. B. A., Sanjaya, I. N. H., Darmawan, E., Aldiansyah, D., Stanojević, M., & Kurjak, A. (2025) · SBV Journal of Basic Clinical and Applied Health Science · doi:10.4103/sbvj.sbvj_45_25 · Cited by 9
Schuurman, L. V. P., de Koning, H. J., Meier, E., Galjaard, R. H., & van Ravesteyn, N. T. (2025) · PLoS Medicine · doi:10.1371/journal.pmed.1004790 · Cited by 14
Xu, C., Cai, X., Chen, S., Luo, Q., Xi, H., Zhang, D., Wang, H., Wu, Y., Huang, H., & Zhang, J. (2021) · BMJ Open · doi:10.1136/bmjopen-2021-053617 · Cited by 9
Ju, J., Li, J., Liu, S. M., Zhang, H., Xu, J., Lin, Y., Gao, Y. M., Zhou, Y., & Jin, X. (2021) · npj Genomic Medicine · doi:10.1038/s41525-021-00247-z · Cited by 9
Wang, J., Wang, W., Zhou, W., Zhou, Y., Zhou, L., Wang, X., Yu, B., & Zhang, B. (2023) · Orphanet Journal of Rare Diseases · doi:10.1186/s13023-023-02903-2 · Cited by 9
Verde, M. L., Marrapodi, M. M., Capristo, C., Conte, A. M., Molitierno, R., Morlando, M., Fordellone, M., FRANCISCIS, P. D., Campitiello, M. R., & Torella, M. (2024) · Minerva Obstetrics and Gynecology · doi:10.23736/s2724-606x.24.05530-1 · Cited by 10
Prenatal genetic care: debates and considerations of the past, present and future
Faas, B. H. W. (2015) · Expert Opinion on Biological Therapy · doi:10.1517/14712598.2015.1045873 · Cited by 9
First trimester prediction and prevention of adverse pregnancy outcomes related to poor placentation
D’Silva, A., Fyfe, R., & Hyett, J. A. (2017) · Current Opinion in Obstetrics & Gynecology · doi:10.1097/gco.0000000000000420 · Cited by 11
Genetic testing and autism: Tutorial for communication sciences and disorders
DeThorne, L. S., & Ceman, S. (2018) · Journal of Communication Disorders · doi:10.1016/j.jcomdis.2018.05.003 · Cited by 9
Imaginaries as infrastructures? The emergence of non-invasive prenatal testing in Austria
Metzler, I. (2019) · BioSocieties · doi:10.1057/s41292-019-00171-7 · Cited by 12
Metadata
- Authors
- Norton, M. E., Jacobsson, B., Swamy, G. K., Laurent, L. C., Ranzini, A. C., Brar, H., Tomlinson, M. W., Pereira, L., Spitz, J. L., Hollemon, D., Cuckle, H., Musci, T. J., & Wapner, R. J.
- Affiliations
- Saint Peter's University Hospital (US)
- Sahlgrenska University Hospital (SE)
- Duke University (US)
- University of California San Diego (US)
- Oregon Health & Science University (US)
- Perinatal Quality Foundation (US)
- Columbia University (US)
- ORCID
- Venue
- New England Journal of Medicine
- Publisher
- Massachusetts Medical Society
- Published
- 2015-04-23
- Volume
- 372
- Issue
- 17
- Pages
- 1589-1597
- ISSN
- 0028-4793 (ISSN-L)
- 1533-4406
- OpenAlex
- W2139926668
- Cited by
- 817
- References
- 32
- Citations by year
- 2026: 33 · 2025: 39 · 2024: 50 · 2023: 59 · 2022: 61 · 2021: 86 · 2020: 72 · 2019: 74 · 2018: 73 · 2017: 86 · 2016: 107 · 2015: 75
- FWCI
- 113.51
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- New England Journal of Medicine (publishedVersion)
- PubMed (publishedVersion)
- eScholarship (California Digital Library) (submittedVersion)
- Funders
- Västra Götalandsregionen
- Thomas Jefferson University
- University of California, San Diego
- University of California, San Francisco
- Topics
- Health Sciences › Medicine › Pediatrics, Perinatology and Child Health › Prenatal Screening and Diagnostics
- Health Sciences › Medicine › Obstetrics and Gynecology › Maternal and Perinatal Health Interventions
- Health Sciences › Medicine › Pediatrics, Perinatology and Child Health › Assisted Reproductive Technology and Twin Pregnancy
- Keywords
- cell-free DNA, prenatal aneuploidy screening, Down syndrome, trisomy 18, trisomy 13, first-trimester screening, nuchal translucency, biochemical analytes, diagnostic accuracy, false positive rate, positive predictive value, non-invasive prenatal testing, maternal age
- MeSH terms
- Adolescent, Adult, Chromosome Aberrations, DNA, Down Syndrome, False Positive Reactions, Female, Fetus, Humans, Middle Aged, Pregnancy, Pregnancy Trimester, First, Prenatal Diagnosis, Prospective Studies, Sensitivity and Specificity, Single-Blind Method, Area Under Curve, Nuchal Translucency Measurement, Young Adult
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.